We bypass the “Pedigree Bottleneck” to deliver high-performing, Competency + Compliance verified technical talent in weeks, not quarters.
Traditional search firms average 90 to 120 days to fill niche scientific roles. According to the Tufts Center for the Study of Drug Development, clinical and commercial delays can cost a sponsor between $600,000 and $8 million per day in lost revenue. You don’t need more resumes; you need milestone protection.
To automated ATS pedigree filters used by generalist HR and legacy headhunters.
The average timeline disruption caused by holding out for the “perfect” PDF resume.
Accumulated cash lost while specialized clinical execution roles remain vacant.
We proactively extract passive talent from "dark pools," delivering interview-ready "Silver Medalist" shortlists in 3 weeks.
We validate technical execution and non-negotiable regulatory standards (21 CFR 211.25 / ISO 13485) before you ever see a resume.
We replace volatile 25% contingent headhunter fees with a scalable Recruitment-as-a-Service model that defends your portfolio's EBITDA.
McKinsey & Company reports that demand for specialized “hybrid” talent is vastly outpacing traditional academic pipelines. We do not staff generalists. We utilize proprietary adjacency mapping to hunt exclusively for the high-scarcity talent that drives innovation and ensures compliance.
Bridging the gap between the “wet lab” and the “dry lab.” We source the hybrid talent that applies AI, Machine Learning, and complex bioinformatics to accelerate drug discovery.
Sourcing the non-negotiable gatekeepers. We deliver zero-defect compliance leaders who possess verified experience navigating complex FDA and EMA pathways.
Decades of industrial-organizational psychology prove that unstructured “culture fit” interviews and legacy degree filters are poor predictors of future performance. We replace subjective guessing with protocol-driven data. Every candidate presented by JLS has survived our Scientific Gauntlet and comes with a Competency + Compliance Scorecard, yielding a predictive validity score of >0.65 (a statistical measure of future on-the-job success).
Verified navigation of specific FDA/EMA frameworks and ISO standards.
Quantified experience with specific LIMS, Veeva, or bench techniques.
Proven track record of taking products from Discovery to Phase I/II/III.
FDA Submissions (IND/NDA)
Expert (4/5)
Veeva Vault RIM Navigation
Advanced (5/5)
Phase II to III Transition
Proficient (3/5)
“Candidate successfully defended an unannounced FDA inspection in Q3 2024 resulting in zero 483 observations. Highly competent in rapid scaling environments.”
We replace volatile 25% contingent headhunter fees with a scalable Recruitment-as-a-Service (RaaS) model.
Harvard Business School recently revealed that rigid applicant tracking systems auto-reject up to 24 million capable individuals. Download the 2026 Competency + Compliance Playbook to learn how to bypass the “Pedigree Bottleneck” and access these hidden, verified talent pools.
Your data is secure. We never sell your information.
